Lumo Labs

Lumo Labs is a venture capital investment firm based in Eindhoven, Netherlands, with an additional office in Los Angeles. It operates as both a venture capital firm and a venture builder, focusing on early-stage companies from pre-seed to series A. Lumo Labs invests in ventures that leverage emerging technologies, including artificial intelligence, blockchain, IoT, and VR/AR, to address significant social challenges. The firm emphasizes sectors such as sustainable cities and communities, health and well-being, and quality education. By connecting innovative start-ups with capital, expertise, and a robust network, Lumo Labs aims to create impactful opportunities that drive technological advancement and social improvement.

Sven Bakkes

Founder

Pim Hollestelle

Investment Associate

Past deals in EEG

Cordys Analytics

Seed Round in 2023
Cordys Analytics specializes in AI-driven cardiac diagnostics. It develops an AI-based platform that interprets electrocardiograms (ECGs), aiding clinicians in early heart disease detection. This technology aims to enhance healthcare accessibility and sustainability by providing timely, accurate diagnoses close to patients, reducing the need for specialized facilities.

AlphaBeats

Seed Round in 2022
AlphaBeats operates a digital mental wellness platform that utilizes a patented, non-invasive method for enhancing mental performance through neuroscience. The platform employs an easy-to-use EEG headset to measure brain activity, allowing for real-time adjustments to user-selected music. This dynamic algorithm is designed to boost alpha brainwave activity, which is essential for achieving optimal mental performance, thereby supporting athletic performance. Additionally, AlphaBeats aims to address the serious social health issues related to the negative impacts of chemical substances often used to enhance athletic performance, particularly among young adults. By merging biofeedback technology with music, the platform helps users reduce stress and achieve a state of relaxation within minutes, offering a unique and effective tool for mental training.

AlphaBeats

Seed Round in 2020
AlphaBeats operates a digital mental wellness platform that utilizes a patented, non-invasive method for enhancing mental performance through neuroscience. The platform employs an easy-to-use EEG headset to measure brain activity, allowing for real-time adjustments to user-selected music. This dynamic algorithm is designed to boost alpha brainwave activity, which is essential for achieving optimal mental performance, thereby supporting athletic performance. Additionally, AlphaBeats aims to address the serious social health issues related to the negative impacts of chemical substances often used to enhance athletic performance, particularly among young adults. By merging biofeedback technology with music, the platform helps users reduce stress and achieve a state of relaxation within minutes, offering a unique and effective tool for mental training.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.